Transcatheter arterial infusion chemotherapy using miriplatin in patients with advanced hepatocellular carcinoma: Prospective randomized study, Lip-TAI vs. Lip+DSM-TAI
Phase of Trial: Phase II
Latest Information Update: 18 May 2017
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 16 May 2017 Status changed from active, no longer recruiting to discontinued.
- 22 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 19 May 2016 New trial record